CardioComm Solutions, Inc.
EKGGF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | -39.9% | -12% | 45.9% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 96.4% | 85.4% | 74.3% | 93.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $0 | $0 | $1 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $1 | $1 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | -$0 | -$0 | $0 | -$0 |
| % Margin | -49.6% | -13.2% | 0.6% | -20.8% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | -$0 | -$0 | -$0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$0 | -$0 | $0 |
| % Margin | -36.9% | -11.1% | -0.2% | 0% |
| EPS | -0.001 | -0.001 | 0 | 0 |
| % Growth | -83.3% | – | – | – |
| EPS Diluted | -0.001 | -0.001 | 0 | 0 |
| Weighted Avg Shares Out | 171 | 151 | 151 | 149 |
| Weighted Avg Shares Out Dil | 171 | 151 | 151 | 149 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | $0 | $0 |
| % Margin | -24.2% | -5% | 5.1% | 8.6% |